The global dietary supplements market was valued at USD 147.1 billion in 2017 and is anticipated to grow at a CAGR of more than 10.2% during the forecast period. Dietary supplements are substances that provide adequate amounts of essential nutrients required for effective functioning of human bodies. The different types of dietary supplements include protein, vitamins, minerals, fiber, fatty acids, and amino acids among others. Dietary supplements are available in the market in a variety of forms such as tablets, capsules, powders, drinks, and energy bars. Some dietary supplements assist in maintaining overall health and managing health conditions. For instance, Vitamin D and calcium provide bone strength and reduce bone loss, whereas folic acid reduces risks of some birth defects.
The growing rate of obesity and increasing number of diseases associated with it primarily drives the growth of the market. Consumers are increasingly becoming aware regarding weight loss, calorie intake, and proper nutrition, thereby supplementing the growth of the market. The increasing need of consumers to lose weight, and stay healthy while maintaining their lifestyles have supported the growth of this market. Other factors driving the market include growing obese population, sedentary lifestyle of consumers leading to lifestyle diseases, increasing disposable income, and growing government initiatives to promote healthy lifestyles. There has been a shift towards e-commerce and consumers are purchasing dietary supplements through online platforms. The variety of choices available coupled with ease of purchase offered by online platforms encourages consumers to buy dietary supplements online, supplementing the growth of the market. Growing demand from emerging economies along with increasing consumer awareness is expected to provide numerous growth opportunities in the coming years.
The global Dietary Supplements market is segmented on the basis of type, form, distribution channel, end-user, and region. Based on type, the market is segmented into vitamins, minerals, amino acids, botanicals, and others. The form segment is categorized into tablets, capsules, powder, soft gels, liquids, and others. On the basis of distribution channel, the market is segmented into offline stores, and online platforms. On the basis of end-users, the market is segmented into adults, children, infants, pregnant women, and geriatric. This report comprises a detailed geographic distribution of the market across North America, Europe, APAC and South America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific. Asia-Pacific accounted for the largest share in the global Dietary Supplements market in 2017.
The leading players in the market are introducing affordable products in the market to cater to the consumers. Global players are entering new markets in developing regions to expand their customer base and strengthen market presence. Herbalife International, a major player in the market offers a wide range of dietary supplements in the market. Its range of dietary supplements includes multivitamin mineral and herbal tablets, personalized protein powder, cell activator tablets, and Cell-U-Loss Advanced among others. Abbott Laboratories is another player in the market, which offers a wide portfolio of nutrition products for adults, infants and new mothers, children, and athletes. In April 2016, EAS, an Abbott company, introduced redesigned Myoplex products to fulfill the nutrition requirements of athletes. The new range of products includes Myoplex Pre-Workout, Myoplex BCAA + Electrolytes, Myoplex Protein Blend, and Myoplex Micellar Casein. Through this launch, the company expanded its offerings in the sports nutrition market. Other leading players in the market include Abott Laboratories, GlaxoSmithKline, Herbalife International, Bayer AG, Pfizer Inc., Nutraceutics Inc., Glanbia Nutritionals, Amway, Carlyle Group, Arkopharma Laboratoires Pharmaceutiques, Bionova Lifesciences, and Danisco A/S among others.